Tao Zhang

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

Oncology, Hepatology, Medicine +10

Lactate Modulates Cellular Metabolism Through Histone Lactylation-Mediated Gene Expression in Non-Small Cell Lung Cancer

Jun Jiang, Dengliang Huang, Yuan Jiang et al. · Frontiers in Oncology · 2021 · 238 citations · Full text

lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis

Yanni Yang, Wenlin Tai, Nihong Lu et al. · Aging · 2020 · 177 citations · Full text

Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial

Rui‐Hua Xu, Kei Muro, Satoshi Morita et al. · The Lancet Oncology · 2018 · 157 citations

Medicine, Pharmacology, Clinical Trials +10

Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells

Joseph Burnett, Gi Lim, Yanyan Li et al. · Cancer Letters · 2017 · 150 citations · Full text

Oncology, Medicine, Anticancer Activity +8